
Pig brains and oxygen chambers: How the super-rich are biohacking their way to immortality
This is Hum2n in Chelsea, one of London's first biohacking centres, which offers cutting-edge treatments in the booming longevity business. That scuba mask is actually a ReOxy device that mimics low oxygen conditions to stimulate lung and heart performance as well as souping up your metabolism. At the helm is Dr Mohammed Enayat, a supreme biohacker himself who has a staff of 28 and plans to open more clinics in London and Saudi Arabia.
The 40-year-old doctor practises what he preaches, travelling the globe trying out treatments himself before giving them to patients. He has twice-monthly IV drips of NAD (nicotinamide adenine dinucleotide), which targets ATP (adenosine triphosphate), the cell's store of energy. He also has regular injections of Cerebrolysin, a mixture of peptides derived from pig brains, for his brain health, and epitalon to stimulate his glands to support stem-cell production. He detoxes using intravenous ozone. And he travels to California for stem-cell-derived exosome infusions. 'I'm doing it for short-, medium- and long-term vitality,' he says, 'for energy, mood, and to prevent disease progression – in short, health span.'
In 2025 the pressing question in Silicon Valley and among the upper echelons of British male society is no longer, 'Who am I?' Instead they're asking, 'How can I become immortal?' Harvard geneticist David Sinclair, the pop star of the longevity world, recently addressed the topic on X. 'If you turned 100 today and felt like you do now, would you want to die? Of course not. So asking how long you want to live is pointless. The right question is, 'When do you want to get frail and sick?''
Male baby boomers watched their parents die and didn't like what they saw. This is motivating them to take their future health into their hands. I have noticed in my own circles that those willing to spend thousands on biohacking technology, and the kit that goes with it, are men. Rich men, I should add, who can afford to undertake this quest for the fountain of youth, and assume the world will want them around for another 100 years. The women I know who have the means to seek eternal life don't. They're worried about being stuck as carers for their antique men, or running around, post-menopausal and wrinkled, after their great-great-grandchildren. Then there's the economics of it all. If we live for more than a century, who's going to pay for it? Certainly not our children. And don't count on investments holding up.
For the moment, though, such considerations are not on the minds of the billionaires pioneering research into longevity. Never mind superyachts, ageing well is set to become the world's most expensive hobby. The entrepreneur Bryan Johnson spends $2 million a year on living longer, while maintaining that he's investing 'for science'. Silicon Valley, and its UK outposts, is ploughing billions into the field.
The biggest spender is OpenAI founder Sam Altman, who in 2022 invested £180 million in Retro Biosciences, a start-up with the stated aim of adding 10 years to a healthy human lifespan. Peter Thiel, co-founder of PayPal, has put $3.5 million into the Methuselah Foundation, a nonprofit that aims to make 90 the new 50 by 2030. Thiel has claimed it will be possible to 'reverse all human ailments in the same way we can fix the bugs of a computer program. Death will eventually be reduced from a mystery to a solvable problem.' Also on the longevity bandwagon are Jeff Bezos, Mark Zuckerberg and Google's Sergey Brin and Larry Page, all of whom have invested millions into companies such as Altos, whose Cambridge lab aims to 'reverse disease and injury'.
Slapping the word 'longevity' on a package can sell anything from protein powders to cosmetics and supplements, hotel spa programmes, gym memberships and even fancy concierge services. One of these, Knightsbridge Circle, has an affiliation with a longevity clinic, Eterna Health, which advertises cell and gene therapy on its website. Netflix devoted a documentary to Johnson, whose activities have included harvesting his own son's blood to inject into himself in the name of immortality – or at least the supplements brand, Blueprint, he now touts. Pale and slim with long hair and the air of a guru, Johnson, 47, is divorced and spends much of his time alone indoors, attached to a machine.
This seems to fly in the face of the fact that 'health span' is predicated on the strength of our familial relationships. Adam Rutherford, a British geneticist, recently tweeted that Johnson 'is going to get in serious medical trouble quite soon', because, despite his claims, he is 'lite' on scientific evidence.
Nevertheless, according to Allied Market Research, the total value of anti-senescence therapies worldwide will grow from $25.1 billion in 2020 to $44.2 billion by 2030. Ever since Japanese scientist Dr Shinya Yamanaka identified four key genes in mice that could be reprogrammed to transform them back into their younger, healthier selves (for which he received a Nobel Prize in 2012), we've been waiting for similar developments in human medicine. But despite the promises, we haven't yet been able to turn the clock back. Even the mice from Yamanaka's initial experiments developed embryonic tumours and that was that. He's since tweaked the genetic cocktail but so far no news flashes.
Dr Enayat has tried many longevity treatments, including rapamycin, which is normally used in liver-transplant patients to suppress the immune system. Off-label (used for a purpose it wasn't designed for) it has been shown to extend the life of fruit flies and worms by 20 per cent. Some American vets give it to elderly dogs. Stem cells may offer hope, but unregulated stem-cell treatments can go very wrong. In 2017 elderly patients in Florida went blind after undergoing stem-cell therapy in a private longevity clinic.
Currently, the only proof of the longevity pudding is how you feel. Simon Ingram, a 70-year-old financier based in Switzerland, is one of Dr Enayat's patients. Before he started the longevity programme last year, he was struggling to work out because of low energy levels, and he slept badly. He wanted some professional guidance.
Since starting at Hum2n, Ingrams has stopped drinking and cleaned up his diet (eating mostly superfoods), and has lost weight and gained muscle. He works out six days a week. 'My strength has increased by 20 per cent,' he says. 'I now have enough energy to work out in the morning then play golf in the afternoon.'
Ingram visits the clinic once a month for three days for an NAD IV drip, ozone therapy, hyperbaric oxygen, cryotherapy, time in the ice closet, EmSculpt (to build muscle) and EmSella (for pelvic-floor strengthening) as well as ReOxy. He estimates that he spends £20,000 a year on all his treatments. 'My friends think I'm mad, that I always take things too far,' he admits. But as well as the gains in strength and fitness, he no longer needs to take medication for a long-term digestive issue. He plans to try peptides next.
These days, leading experts in longevity medicine are looking at five specific areas. These are epigenetics, which is how your behaviour and environment change how your genes work; telomeres, the DNA sequences at the end of chromosomes, which shorten with age; senescence and cellular repair, which involves understanding why cells go rogue and how to stop it happening; stem cells, and anti-ageing regenerative medicine. The last of these involves five-hour-long NAD drips to repair DNA damage and increase energy; metabolic manipulation with Ozempic, and intermittent fasts, and all the hi-tech stuff such as wearable tech that gives instant feedback as to the state of your various organs.
The current fad in longevity circles is to state your biological age (as gauged by the GlycanAge test, which measures your cellular levels of chronic inflammation), rather than your actual date of birth. Is this popularity related to the fact that everyone, including me, seems to notch up a GlycanAge that's 10 years less than their birth certificate proclaims? This had the inevitable consequence of leading Dutch positivity coach Emile Ratelband, at 69, to attempt to have his passport age adjusted downwards to 49, to reflect the age he felt himself to be, to get better Tinder dates. He failed.
Diet, exercise (which promotes stem-cell creation), sleep (how we renew and detox), nutrition and, most of all, human interactions, are key to 'health span'. Something as simple as a flu jab can influence cells, says Dr Michael Roizen, chief wellness officer of the private hospital company Cleveland Clinic. 'The main thing to understand about rebooting your life is that you are a genetic engineer,' he says. Meditation alone can elongate telomeres and thus slow down ageing. So may inhaling menthol, drinking black coffee, wearing a hearing aid to stay connected, and lashings of virgin olive oil. Genes account for only 25 per cent of how we age. 'The rest is environment and lifestyle,' says Dr Thomas Perls of Boston University. 'Though this flips on its head as one approaches the age of 100.'
Clinique La Prairie (CLP) in Montreux, overlooking Lake Geneva, is where the rich, the famous, and the royal come for the most advanced anti-ageing procedures in Europe under the eye of 50 medical specialists.
The Swiss health resort has recently thrown itself big time into the longevity business, with plans to open 10 new resorts and 40 'hubs' worldwide. John Cleese has been coming here every 12 to 18 months for the past two decades to buy himself some extra years. Its big sell is the seven-day 'revitalisation' programme, which relies on a secret, patented CLP Extract formula, first created in 1931.
Part of the CLP programme is epigenetic testing. This is a new way of pinpointing biological age and specific areas that can be targeted to reduce it. In my case, cutting back on alcohol could dramatically change my age, the doctor told me. The test is so sensitive it even detected that I had recently been to India by picking up certain pollutants. The clinic also tests bloods and stools, and screens for heavy metals in the body using a new device, the OligoScan.
In order to prepare the body for the mysterious CLP Extract (which they combine with immunostimulants), guests are given multiple injections of glutathione (an antioxidant), as well as a dose of an immunomodulating bacteria along with a potent drink derived from grapes for maximum oxygen uptake in the small blood vessels. Though sadly, it's not wine. None of these steps can be skipped or fiddled or the magic won't work. On top of that is the anti-inflammatory plant-based diet, and treatments including cryotherapy, sound therapy and infratherapy in a tunnel-like sauna that makes you sweat out impurities from deep within. I could see grey flecks on the towels I used after the sauna. They were either from the pollution that I was sweating out, or perhaps my body was saying goodbye to the cadmium that can be found in even the most expensive chocolates.
The youthful-looking Dr Adrian Heini oversees the revitalisation programme, which can cost upwards of £25,000 for the week. He won't reveal what goes into the age-reversing potion but says, 'We prefer to keep it natural.' Guests who come annually report feeling considerably more energetic and suffering from fewer colds. Many say they never caught Covid. An attendant told me that most clients used to be older men, but now there are young ones too. And women as well as men. Those I saw did not fraternise – tables are spread far apart in the dining room – but they ranged in age from 20s to 80s. CLP recently launched a supplement version of the age reversal formula called Age-Defy which retails for £655 for a two-month supply. It claims to combat oxidative stress, targets telomeres and includes many popular anti-senescent agents such as the plant extract fisetin, as well as a proprietary antioxidant formula.
The thing about longevity is that you have to buy into the promise. Proof is thin on the ground – how can we know if someone made it to age 90 because of NAD drips rather than lucky genes? And what if all the biological tweaks make no difference at all, or even speed up cancer, which is a genuine risk of some longevity treatments?
But there are profits to be made. Newly opened in Marylebone, Clarify Clinic offers to rid your blood of all microplastics, chemicals and inflammatory cytokines using a process called apheresis – and you won't get much change from £10,000. I know long-Covid sufferers who have spent £50,000 and more on this treatment abroad, only to get sicker. Henry S Lodge, the co-author of the best-selling Younger Next Year (2004), died of cancer aged 58. An early death is something many anti-ageing experts have in common.
Whenever we get excited about the latest age-cracking revelation, someone comes along and sticks a pin in it. Take the 'blue zones' research, which looked at lifestyles in relatively poor areas of Sardinia, Okinawa and Costa Rica's Nicoya Peninsula, where people appeared to live to extreme old age. The study concluded that to make it to 110 you have to eat algae, chat in cafés and walk 20 miles a day (I paraphrase). However, the methodology of the research was debunked when separate researchers found that almost all the centenarians involved were in fact long dead and their relatives pretended they were still alive to keep collecting their pensions. It is, I suppose, one form of immortality. Dan Buettner, the author of The Blue Zones: Lessons for Living Longer, nevertheless now runs a mini empire of which the Blue Zones Kitchen ready-meal range (Heirloom Rice Bowl, Peach Pecan Steel Cut Oatmeal…) is one manifestation.
We will crack the ageing code, or some of it at least, but for now we should curb our enthusiasm, says Dr William Mair, director of the Harvard TH Chan School Aging Initiative. 'There are increasing numbers of health influencers who have almost an evangelical following and make bold statements about how to live longer, [using] for example, ice therapy, heat shock, and so on,' he recently wrote in a Harvard publication. 'What they are doing is extrapolating data – from simpler organisms, small sample studies, and non-causal correlative studies – and telling people it's the truth. That's not how the scientific process works.' When I asked him if humans will be able to live to 300 one day, he replied, 'I don't know, yet. But that's not going to get me a lot of hits on TikTok, is it?'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
3 hours ago
- The Independent
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn't pay to fix the problem and she sank back into a dangerous darkness. She worried for her life, asking herself: 'Why am I putting myself through this?' Seeger's predicament highlights a growing problem for hundreds of people with experimental neural implants, including those for depression, quadriplegia and other conditions. Although these patients take big risks to advance science, there's no guarantee that their devices will be maintained — particularly after they finish participating in clinical trials — and no mechanism requiring companies or insurers to do so. A research project led by Gabriel Lázaro-Muñoz, a Harvard University scientist, aimed to change that by creating partnerships between players in the burgeoning implant field to overcome barriers to device access and follow-up care. But the cancellation of hundreds of National Institutes of Health grants by the Trump administration this year left the project in limbo, dimming hope for Seeger and others like her who wonder what will happen to their health and progress. An ethical quagmire Unlike medications, implanted devices often require parts, maintenance, batteries and surgeries when changes are needed. Insurance typically covers such expenses for federally approved devices considered medically necessary, but not experimental ones. A procedure to replace a battery alone can cost more than $15,000 without insurance, Lázaro-Muñoz said. While companies stand to profit from research, 'there's really nothing that helps ensure that device manufacturers have to provide any of these parts or cover any kind of maintenance,' said Lázaro-Muñoz. Some companies also move on to newer versions of devices or abandon the research altogether, which can leave patients in an uncertain place. Medtronic, the company that made the deep brain stimulation, or DBS, technology Seeger used, said in a statement that every study is different and that the company puts patient safety first when considering care after studies end. People consider various possibilities when they join a clinical trial. The Food and Drug Administration requires the informed consent process to include a description of 'reasonably foreseeable risks and discomforts to the participant,' a spokesperson said. However, the FDA doesn't require trial plans to include procedures for long-term device follow-up and maintenance, although the spokesperson stated that the agency has requested those in the past. While some informed consent forms say devices will be removed at a study's end, Lázaro-Muñoz said removal is ethically problematic when a device is helping a patient. Plus, he said, some trial participants told him and his colleagues that they didn't remember everything discussed during the consent process, partly because they were so focused on getting better. Brandy Ellis, a 49-year-old in Boynton Beach, Florida, said she was desperate for healing when she joined a trial testing the same treatment Seeger got, which delivers an electrical current into the brain to treat severe depression. She was willing to sign whatever forms were necessary to get help after nothing else had worked. 'I was facing death,' she said. 'So it was most definitely consent at the barrel of a gun, which is true for a lot of people who are in a terminal condition.' Patients risk losing a treatment of last resort Ellis and Seeger, 64, both turned to DBS as a last resort after trying many approved medications and treatments. 'I got in the trial fully expecting it not to work because nothing else had. So I was kind of surprised when it did,' said Ellis, whose device was implanted in 2011 at Emory University in Atlanta. 'I am celebrating every single milestone because I'm like: This is all bonus life for me.' She's now on her third battery. She needed surgery to replace two single-use ones, and the one she has now is rechargeable. She's lucky her insurance has covered the procedures, she said, but she worries it may not in the future. 'I can't count on any coverage because there's nothing that says even though I've had this and it works, that it has to be covered under my commercial or any other insurance,' said Ellis, who advocates for other former trial participants. Even if companies still make replacement parts for older devices, she added, 'availability and accessibility are entirely different things,' given most people can't afford continued care without insurance coverage. Seeger, whose device was implanted in 2012 at Emory, said she went without a working device for around four months when the insurance coverage her wife's job at Emory provided wouldn't pay for battery replacement surgery. Neither would Medicare, which generally only covers DBS for FDA-approved uses. With her research team at Emory advocating for her, Seeger ultimately got financial help from the hospital's indigent care program and paid a few thousand dollars out of pocket. She now has a rechargeable battery, and the device has been working well. But at any point, she said, that could change. Federal cuts stall solutions Lázaro-Muñoz hoped his work would protect people like Seeger and Ellis. 'We should do whatever we can as a society to be able to help them maintain their health,' he said. Lázaro-Muñoz's project received about $987,800 from the National Institute of Mental Health in the 2023 and 2024 fiscal years and was already underway when he was notified of the NIH funding cut in May. He declined to answer questions about it. Ellis said any delay in addressing the thorny issues around experimental brain devices hurts patients. Planning at the beginning of a clinical trial about how to continue treatment and maintain devices, she said, would be much better than depending on the kindness of researchers and the whims of insurers. 'If this turns off, I get sick again. Like, I'm not cured,' she said. 'This is a treatment that absolutely works, but only as long as I've got a working device.' ____ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


Telegraph
3 hours ago
- Telegraph
New contraceptive pill for men is safe, study suggests
A new male contraceptive pill tested on British men in a world first is safe for use, a study suggests. Oral female contraceptive tablets have been available for 60 years but there has never been an authorised male version. Female tablets work by altering hormone levels to reduce the risk of conception but this approach has proven difficult in men because of severe side effects such as infertility and mood swings. These side effects are common in female versions. A third of men say they would take a contraceptive pill if one was available to them. YourChoice Therapeutics has developed the first non-hormonal contraceptive for men which works by blocking the production of a protein, which is needed to produce sperm, and not meddling with hormones. The drug stops production of retinoic acid receptor alpha (RAR-alpha) in the body and this prevents it binding to vitamin A compounds and subsequently prevents sperm production. Animal studies showed this mechanism to be 99 per cent effective and also found that sperm levels returned to normal after the medication was stopped, showing the contraceptive to be temporary and reversible. Human trials began in 2023 when 16 healthy men who had already had a vasectomy were recruited to test the safety of the drug in people. Data, published this week, show it to be safe and well-tolerated with no clinically relevant side effects in a significant step forward for the prospects of the drug, known as YCT-529. The trial of 16 British men gave participants either the tablet or a placebo and conducted analysis on the participants to measure their blood, urine, mood and overall health. Four different dosages were tested and all were found to be well-tolerated. The highest dose was the same as what was shown to be effective as a contraceptive in animal trials. 'Positive results' There was no reduction in testosterone levels, sex drive or any other hormonal imbalance, the scientists found. 'The positive results from this first clinical trial laid the groundwork for a second trial, where men receive YCT-529 for 28 days and 90 days, to study safety and changes in sperm parameters,' the study authors write in their peer-reviewed study in the journal Communications Medicine. Further trials will now gather more data on the long-term safety profile of the drugs and if this is found to be acceptable, the next stage of clinical trials will begin to determine its precise effectiveness in humans. The data are needed before regulators can make a decision on whether a drug is safe and effective enough to be approved for human use. The study authors add that the safety bar for contraceptives is much higher and harder to reach than it is for drugs designed to cure or treat a disease because it is preventative and used by healthy people daily for a long period of time. 'More attractive to men' Akash Bakshi, a co-founder and the chief executive of YourChoice, has previously suggested the medicine, if approved, could be sent out alongside at-home testing kits for men to check their sperm levels are too low to cause pregnancy. He said: 'YCT-529 blocks a protein – not hormones – to prevent sperm production. We believe this will be more attractive to men, most of whom view pregnancy prevention as a shared responsibility even despite today's limited contraceptive options, which are permanent or only moderately effective. 'The dearth of options reinforces the centuries-old view that pregnancy prevention is 'a woman's responsibility'. It's not, and we're committed to advancing the first hormone-free birth control pill for men that's effective, convenient, and temporary.' While non-hormonal male contraceptives are in trials and at the early stage of development and testing, other hormone-powered alternatives are also in the works. A gel which is rubbed into the shoulders of a man every day is one such medicine and contains Nestorone (segesterone acetate) and testosterone. This lowers sperm counts in around eight weeks and is in testing currently on more than 200 men in the US. The gel is rubbed into the shoulders or shoulder blades because it is easy to reach for the user and it is also unlikely a child or woman would come into direct contact with the gel in this location. The hormones soak into the skin and are absorbed by the bloodstream. But accidental exposure to the gel could cause premature puberty in children and acne or excessive hair growth in women.


Daily Record
4 hours ago
- Daily Record
Scots gran dies in Alicante airport after taking unwell in taxi on return from holiday
Angela McTier suffered a ruptured varicose vein which led to significant blood loss. A Scots gran tragically died in a Spanish airport on her way back from holiday. Angela McTier, from Blantyre in Lanarkshire, was heading to Alicante airport in a taxi when she suffered a ruptured varicose vein, causing significant blood loss. The 48-year-old reached the airport but she lost consciousness at the departure lounge and despite resuscitation attempts, she sadly died at the scene on July 22. Her daughter, Michelle Hilston, told STV that her mum had been trying to improve her health so she could watch her granddaughters grow up. The 24-year-old said: "My mum watched the grandkids at least two nights every week and always looked forward to them coming over. I'm heartbroken for my two girls who have just lost that special relationship with her. 'If there's one thing my mum loved, it was going on holiday, she thrived over there and this particular holiday to La Mata she just kept saying how amazing it was, it was her best holiday and she'd felt so well and couldn't wait to bring the grandkids over. 'She was due to go away with me and my two toddlers next month as well.' Michelle revealed that her mum gave her invaluable support when she was working towards achieving a degree in midwifery. She sent her mum a video of her 11-month-old granddaughter taking her first steps. Michelle added: 'She helped me out so much to pursue my dream degree after having my kids and always made sure I had all the childcare and financial support I needed. 'Her holidays were a special thing for her, she went multiple times a year, and it was one of the things she loved doing the most. 'But the thing she loved the most was her granddaughters and would ask for pictures of them multiple times a day. 'The day she died, I had sent her a video of my 11-month-old finally walking, and she was in tears over the video, phoning everyone to tell them, and I'm glad that's the last video she saw of the kids.' A FCDO Spokesperson said: 'We are supporting the family of a British woman who died in Spain.' A GoFundMe has been set up to help with the costs of repatriating Angela and her funeral.